Filomena Adega Selected Research

Biological Therapy

1/2012

Defining the sister rat mammary tumor cell lines HH-16 cl.2/1 and HH-16.cl.4 as an in vitro cell model for Erbb2.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Filomena Adega Research Topics

Disease

7	Neoplasms (Cancer) 01/2023 - 01/2015
3	Breast Neoplasms (Breast Cancer) 12/2019 - 01/2012
1	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 08/2023
1	Lung Neoplasms (Lung Cancer) 08/2023
1	Spinal Muscular Atrophy (Progressive Muscular Atrophy) 05/2022
1	Lymphatic Metastasis 01/2019
1	Hepatocellular Carcinoma (Hepatoma) 12/2011
1	Papillary Carcinoma 02/2007
1	Carcinoma (Carcinomatosis) 02/2007
1	Chromosomal Instability (Chromosome Stability) 03/2006
1	Fibrosarcoma 03/2006
1	Chromosome Aberrations (Chromosome Abnormalities) 03/2006

Drug/Important Bio-Agent (IBA)

4	Biomarkers (Surrogate Marker)IBA 08/2023 - 09/2015
3	DNA (Deoxyribonucleic Acid)IBA 11/2022 - 02/2007
3	RNA (Ribonucleic Acid)IBA 11/2022 - 01/2019
3	Satellite DNA (Satellite DNAs)IBA 01/2019 - 03/2006
1	ErbB Receptors (EGF Receptor)IBA 08/2023
1	Smart MaterialsIBA 01/2023
1	Doxorubicin (Adriamycin)FDA LinkGeneric 01/2023
1	Estrogen ReceptorsIBA 11/2022
1	Retroelements (Retrotransposon)IBA 05/2022
1	RibonucleoproteinsIBA 04/2020
1	Tumor Biomarkers (Tumor Markers)IBA 01/2019
1	benzocycloheptapyridineIBA 12/2011

Therapy/Procedure

4	Therapeutics 01/2023 - 01/2015
1	Precision Medicine 11/2022
1	Biological Therapy 01/2012